AZABENZOFURAN SUBSTITUTED THIOUREAS AS INHIBITORS OR VIRAL REPLICATION
Application 4144/DELNP/2006 published 2007-07-13, filed 2006-07-18
The present invention provides compounds of Formula: (1), wherein the variables Ar, A1, A2, A3, A4, R5, R6, R7, V, W, X, and Y are defined herein. Certain compounds of Formula (1) described herein possess potent antiviral activity. The invention also provides compounds of Formula (1) that are potent and/ or selective inhibitors of Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more compounds of Formula (1), or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents. The invention further comprises methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula (1) effective to reduce signs or symptoms of the disease. These infectious diseases include viral infections, particularly HIV infections. The invention is particularly includes methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease. Methods of treatment include administering a compound of Formula (1) as a single active agent or administering a compound of Formula (1) in combination with on or more other therapeutic agent.
Applicant
1)ACHILLION PHARMACEUTICALS, INC.
:300 GEORGE STREET, NEW HAVEN, CT 06511
Inventor
1)THURKAUF, ANDREW 2)CHEN, DAWEI 3)PHADKE, AVINASH 4)LI, SHOUMING 5)DESHPANDE, MILIND
International Info
Classification: A61K 31/00
Publication Number: WO 2005/067900
Application Date: 2005-01-05
Priority Information
60/534,839 U.S.A. 2004-01-06